BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dong S, Zhan ZY, Cao HY, Wu C, Bian YQ, Li JY, Cheng GH, Liu P, Sun MY. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(15): 2771-2784 [PMID: 28487615 DOI: 10.3748/wjg.v23.i15.2771]
URL: https://www.wjgnet.com/1948-5182/full/v23/i15/2771.htm
Number Citing Articles
Kara Wegermann, Catherine Howe, Ricardo Henao, Ying Wang, Cynthia D. Guy, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan. Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver DiseaseHepatology Communications 2021; 5(4): 608 doi: 10.1002/hep4.1665
Zohre Mozduri, Nathalie Marty-Gasset, Bara Lo, Ali Akbar Masoudi, Mireille Morisson, Cécile Canlet, Julien Arroyo, Agnès Bonnet, Cécile M. D. Bonnefont. Identification of Plasmatic Biomarkers of Foie Gras Qualities in Duck by MetabolomicsFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.628264
Yuri A. Lawrence, Blake C. Guard, Jörg M. Steiner, Jan S. Suchodolski, Jonathan A. Lidbury, Juan J. Loor. Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic diseasePLOS ONE 2019; 14(5): e0217797 doi: 10.1371/journal.pone.0217797
Niama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, Jun Yu. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancerCancer Letters 2019; 459: 186 doi: 10.1016/j.canlet.2019.114425
Qian Feng, Yuanmeng Li, Yuwei Yang, Jiafu Feng. Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney DiseaseFrontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.578799
Lucia Carulli, Giulia Zanca, Filippo Schepis, Erica Villa. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)Metabolites 2019; 9(2): 25 doi: 10.3390/metabo9020025
Aihua Zhang, Qiang Yang, Hui Sun, Xijun Wang. Mass Spectrometry‐Based Metabolomics in Clinical and Herbal Medicines2021; : 1 doi: 10.1002/9783527835751.ch1
Ying Zhu, Qingce Zang, Zhigang Luo, Jiuming He, Ruiping Zhang, Zeper Abliz. An Organ-Specific Metabolite Annotation Approach for Ambient Mass Spectrometry Imaging Reveals Spatial Metabolic Alterations of a Whole Mouse BodyAnalytical Chemistry 2022;  doi: 10.1021/acs.analchem.2c00557
Dragana Savic, Leanne Hodson, Stefan Neubauer, Michael Pavlides. The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)Nutrients 2020; 12(8): 2178 doi: 10.3390/nu12082178
Tao Tang, Ya Li, Jie Wang, Mauricio A. Elzo, Jiahao Shao, Yanhong Li, Siqi Xia, Huimei Fan, Xianbo Jia, Songjia Lai. Untargeted Metabolomics Reveals Intestinal Pathogenesis and Self-Repair in Rabbits Fed an Antibiotic-Free DietAnimals 2021; 11(6): 1560 doi: 10.3390/ani11061560
Eugenia Carril, María Pilar Valdecantos, Borja Lanzón, Santiago Angulo, Ángela M. Valverde, Joanna Godzien, Francisco Javier Rupérez. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient dietJournal of Pharmaceutical and Biomedical Analysis 2020; 178: 112958 doi: 10.1016/j.jpba.2019.112958
Lars Ove Dragsted, Kajetan Trošt. The Human Gut-Liver-Axis in Health and Disease2019; : 147 doi: 10.1007/978-3-319-98890-0_10
George N. Ioannou, G. A. Nagana Gowda, Danijel Djukovic, Daniel Raftery. Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics ApproachMetabolites 2020; 10(4): 168 doi: 10.3390/metabo10040168
Jose Rodríguez-Morató, Óscar J Pozo, Josep Marcos. Targeting human urinary metabolome by LC–MS/MS: a reviewBioanalysis 2018; 10(7): 489 doi: 10.4155/bio-2017-0285
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, Enara Arretxe, Cristina Alonso, Melania Gaggini, Julia Brosnan, Quentin M. Anstee, Oscar Millet, Pablo Ortiz, Jose M. Mato, Jean-Francois Dufour, Matej Orešič. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic testsNature Reviews Gastroenterology & Hepatology 2021; 18(12): 835 doi: 10.1038/s41575-021-00502-9
Runbin Sun, Haokai Zhao, Shuzhen Huang, Ran Zhang, Zhenyao Lu, Sijia Li, Guangji Wang, Jiye Aa, Yuan Xie. Prediction of Liver Weight Recovery by an Integrated Metabolomics and Machine Learning Approach After 2/3 Partial HepatectomyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.760474
Xiao-jun Gou, Shanshan Gao, Liang Chen, Qin Feng, Yi-yang Hu. A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat DietBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5920485
Brianna Cyr, Robert W. Keane, Juan Pablo de Rivero Vaccari. ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept StudyInternational Journal of Molecular Sciences 2020; 21(22): 8580 doi: 10.3390/ijms21228580
Application of Metabolomics in Diagnosis and Treatment of Chronic Liver DiseasesCritical Reviews in Analytical Chemistry 2020; : 1 doi: 10.1080/10408347.2020.1842172
George V. Dedoussis, Athina I. Amanatidou. NAFLD and NASH2020; : 181 doi: 10.1007/978-3-030-37173-9_10
Danial Efendy Goon, Sharaniza Ab-Rahim, Amir Hakimi Mohd Sakri, Musalmah Mazlan, Jen Kit Tan, Mardiana Abdul Aziz, Norizal Mohd Noor, Effendi Ibrahim, Siti Hamimah Sheikh Abdul Kadir. Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MSScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00454-9
Lili Niu, Karolina Sulek, Catherine G. Vasilopoulou, Alberto Santos, Nicolai J. Wewer Albrechtsen, Simon Rasmussen, Florian Meier, Matthias Mann. Defining NASH from a Multi-Omics Systems Biology PerspectiveJournal of Clinical Medicine 2021; 10(20): 4673 doi: 10.3390/jcm10204673
David S. Wishart. Metabolomics for Investigating Physiological and Pathophysiological ProcessesPhysiological Reviews 2019; 99(4): 1819 doi: 10.1152/physrev.00035.2018
Ji-Hee Haam, Yun Kyong Lee, Eunkyung Suh, Young-Sang Kim. Characteristics of Urine Organic Acid Metabolites in Nonalcoholic Fatty Liver Disease Assessed Using Magnetic Resonance Imaging with Elastography in Korean AdultsDiagnostics 2022; 12(5): 1199 doi: 10.3390/diagnostics12051199
Mingzhe Zhu, Meng Li, Wenjun Zhou, Guangbo Ge, Li Zhang, Guang Ji. Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia RatsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00671
Diren Beyoğlu, Jeffrey R. Idle. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and TherapyMetabolites 2020; 10(2): 50 doi: 10.3390/metabo10020050
Xiangnan Ren, Wu Fan, Zixing Shao, Kaiyun Chen, Xuefeng Yu, Qionglin Liang. A metabolomic study on early detection of steroid-induced avascular necrosis of the femoral headOncotarget 2018; 9(8): 7984 doi: 10.18632/oncotarget.24150
Isabelle Alldritt, Paul L. Greenhaff, Daniel J. Wilkinson. Metabolomics as an Important Tool for Determining the Mechanisms of Human Skeletal Muscle DeconditioningInternational Journal of Molecular Sciences 2021; 22(24): 13575 doi: 10.3390/ijms222413575
Ambrin Farizah Babu, Susanne Csader, Ville Männistö, Milla-Maria Tauriainen, Heikki Pentikäinen, Kai Savonen, Anton Klåvus, Ville Koistinen, Kati Hanhineva, Ursula Schwab. Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stoolScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-10481-9
Stefano Gitto, Filippo Schepis, Pietro Andreone, Erica Villa. Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical PerspectivesMetabolites 2018; 8(1): 17 doi: 10.3390/metabo8010017
Huikuan Chu, Yi Duan, Ling Yang, Bernd Schnabl. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver diseaseGut 2019; 68(2): 359 doi: 10.1136/gutjnl-2018-316307
Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros. The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver diseaseMetabolism 2020; 111: 154320 doi: 10.1016/j.metabol.2020.154320
Liyan Liu, Jinhui Zhao, Runan Zhang, Xuemei Wang, Yan Wang, Yang Chen, Rennan Feng. Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver diseaseJournal of Pharmaceutical and Biomedical Analysis 2021; 200: 114058 doi: 10.1016/j.jpba.2021.114058
Da Jung Kim, Seonghae Yoon, Sang Chun Ji, Jinho Yang, Yoon-Keun Kim, SeungHwan Lee, Kyung-Sang Yu, In-Jin Jang, Jae-Yong Chung, Joo-Youn Cho. Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30349-1
Qiang Yang, Ai-hua Zhang, Jian-hua Miao, Hui Sun, Ying Han, Guang-li Yan, Fang-fang Wu, Xi-jun Wang. Metabolomics biotechnology, applications, and future trends: a systematic reviewRSC Advances 2019; 9(64): 37245 doi: 10.1039/C9RA06697G
Wei-Wei Li, Yan Yang, Qi-Gang Dai, Li-Li Lin, Tong Xie, Li-Li He, Jia-Lei Tao, Jin-Jun Shan, Shou-Chuan Wang. Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndromeMetabolomics 2018; 14(7) doi: 10.1007/s11306-018-1387-z
Emma J. Robinson, Matthew C. Taddeo, Xin Chu, Weixing Shi, Craig Wood, Christopher Still, Virginia G. Rovnyak, David Rovnyak. Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR MetabolomicsMetabolites 2021; 11(11): 737 doi: 10.3390/metabo11110737
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiomeWorld Journal of Hepatology 2021; 13(11): 1494-1511 doi: 10.4254/wjh.v13.i11.1494
Ahmad Moolla, Jasper de Boer, David Pavlov, Amin Amin, Angela Taylor, Lorna Gilligan, Beverly Hughes, John Ryan, Eleanor Barnes, Zaki Hassan-Smith, Jane Grove, Guruprasad P. Aithal, An Verrijken, Sven Francque, Luc Van Gaal, Matthew J. Armstrong, Phillip N. Newsome, Jeremy F. Cobbold, Wiebke Arlt, Michael Biehl, Jeremy W. Tomlinson. Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolomeAlimentary Pharmacology & Therapeutics 2020; 51(11): 1188 doi: 10.1111/apt.15710
Maria Del Ben, Diletta Overi, Licia Polimeni, Guido Carpino, Giancarlo Labbadia, Francesco Baratta, Daniele Pastori, Valeria Noce, Eugenio Gaudio, Francesco Angelico, Carmine Mancone. Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASHInternational Journal of Molecular Sciences 2018; 19(2): 603 doi: 10.3390/ijms19020603
Elisa Gurian, Pablo Giraudi, Natalia Rosso, Claudio Tiribelli, Deborah Bonazza, Fabrizio Zanconati, Michela Giuricin, Silvia Palmisano, Nicolò de Manzini, Valter Sergo, Alois Bonifacio. Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopyAnalytica Chimica Acta 2020; 1110: 190 doi: 10.1016/j.aca.2020.02.040